on TVM Life Science Management GmbH
TVM Capital Life Science to Participate in LSI Europe ’24 Emerging Medtech Summit 2024
Munich, Germany and Montreal, Quebec, Canada – TVM Capital Life Science, a venture capital firm focused on life sciences innovation, announced its participation in the LSI Europe ’24 Emerging Medtech Summit. Scheduled for September 16-20, 2024, in Sintra, Portugal, the event will bring together leading medtech innovators, investors, and strategists.
Dr. Luc Marengère, Managing Partner, cited the company's focus on breakthrough solutions that could redefine the standard of care. Dr. Hubert Birner, also a Managing Partner, emphasized TVM's commitment to supporting transformative healthcare solutions.
TVM adopts a dual investment strategy, engaging in both late-stage medtech and early-stage therapeutics. This approach includes notable companies like Kent Imaging and Vektor Medical from its portfolio, showcasing their cutting-edge technologies at the summit.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all TVM Life Science Management GmbH news